afdx 116 has been researched along with xanomeline in 1 studies
| Studies (afdx 116) | Trials (afdx 116) | Recent Studies (post-2010) (afdx 116) | Studies (xanomeline) | Trials (xanomeline) | Recent Studies (post-2010) (xanomeline) |
|---|---|---|---|---|---|
| 367 | 1 | 24 | 124 | 16 | 41 |
| Protein | Taxonomy | afdx 116 (IC50) | xanomeline (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.1644 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0251 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.3967 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehnicke, C; Deisz, RA; Gigout, S; Horn, P; Lehmann, TN; Wierschke, S | 1 |
1 other study(ies) available for afdx 116 and xanomeline
| Article | Year |
|---|---|
Muscarinic acetylcholine receptor-mediated effects in slices from human epileptogenic cortex.
Topics: Action Potentials; Adult; Biophysics; Carbachol; Cerebral Cortex; Cholinergic Agonists; Drug Combinations; Electric Stimulation; Epilepsy; Excitatory Postsynaptic Potentials; Female; Humans; In Vitro Techniques; Male; Muscarinic Antagonists; Patch-Clamp Techniques; Pirenzepine; Pyridines; Receptors, Muscarinic; Thiadiazoles | 2012 |